|
M.B. Antsiferov
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
|
№5 / 2016
|
|
A.S. Ametov
ADVANTAGES OF FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE (KOMBOGLYCE PROLONG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№5 / 2015
|
|
А.А. Yuryatin
THE SAVOR TRIAL: THE BEGINNING OF THE NEW ERA OF SAFE PHARMACOTHERAPY FOR TYPE-2 DIABETES MELLITUS
|
№5 / 2014
|
|
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
A.S. Ametov, MD, Professor; A.V. Braschenkova
Rational Pharmacotherapy Of Type 2 Diabetes Mellitus: Use Of Dpp-4 Inhibitor Saxagliptin And Metformin In Clinical Practice
|
№16 / 2012
|
|
M.B. Antsiferov (1), N.A. Petunina (2)
Type 2 Diabetes Mellitus And Concomitant Diseases: Advantages Of Use Of Dipeptidyl Peptidase-4 Inhibitor Saxagliptin (onglyza ®)
|
№3 / 2012
|
|
N.A. Petunina, A.V. Brashcenkova
Saxagliptin (onglyza ®) In Conception Of Effective Management Of Type 2 Diabetes Mellitus
|
№16 / 2011
|
|
A.M. Mkrtumyan
Saxagliptin Opens New Opportunities For Effective And Safe Glycemic Control In Patients With Type 2 Diabetes Mellitus
|
№16 / 2010
|
Русский
